BOOK

E-Health, Privacy, and Security Law, Third Edition

This treatise provides health law practitioners and e-health professionals with a full exploration of the legal, regulatory, transactional, and ethical issues at the nexus of health and information technology, including e-health, privacy, security, social media, HIPAA, HITECH, and more. It also includes guidance on maximizing technology to cut costs and improve marketing, all while staying compliant and avoiding penalties.

 

Price: $495.00 Main Volume

DESCRIPTION

CLEAR INFORMATION on the full range of today’s e-health business and transactional law issues 

 

The new Third Edition includes updated chapters on the e-health industry and health information technology, as well as discussion of:

  • recent security breach settlements with HHS’s Office for Civil Rights (OCR) and the implications, as well as a new chapter on other cybersecurity developments in healthcare
  • how health information technologies will play a key role in the shift from fee-for-service medicine to payment for quality and cost-effectiveness;
  • the European Data Privacy Regime, including the Data Protection Directive, and key changes the General Data Protection Regulation (GDPR) will bring, such as mandatory breach reporting and significant fines.
  • OCR's Phase 2 HIPAA compliance audit program, evaluating compliance with privacy, security, and breach notification rules
  • the impact of patient-generated health data, including that originating with mobile and wearable devices;
  • the increasing use of telemedicine, both in the U.S. and globally, and the barriers to it;
  • HHS’s imposition of civil monetary penalties (CMP) under HIPAA, as well as new actions brought by state attorneys general under the HITECH Act; and
  • FDA warning letters related to social media promotion of pharmaceutical and dietary supplement products, and FDA final guidance detailing the regulatory scheme for mobile medical apps.
  • the Part 2 Regulations Proposed Rule from the Substance Abuse and Mental Health Services Administration (SAMHSA) of HHS on the exchange of substance use disorder information
  • the Stage 3 Final Rule under the American Recovery and Reinvestment Act (ARRA) specifying the requirements that eligible professionals and hospitals must meet to qualify for Medicare and Medicaid EHR incentive payments;
  • the FTC’s Health Breach Notification Rule (“HBNR”) and its applicability to PHR vendors, PHR-related entities, and third-party service providers

 


AUTHORS

Bloomberg BNA authors and editors are practicing professionals with insider perspectives and real-life experience. Learn more about this book’s authors and editors.
W. Andrew H. Gantt III is a partner in Cooley LLP, Washington, DC, and a member of its Life Sciences Practice Group. He also leads Cooley’s Health Care Regulatory Practice.


CONTENTS

View full tables of contents and read the book’s preface or introduction.